DK605989A - Propenonoximethere og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem - Google Patents

Propenonoximethere og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem Download PDF

Info

Publication number: DK605989A
Authority: DK; Denmark
Prior art keywords: propenonoxymethers; procedures; preparing; pharmaceutical agents; agents containing
Prior art date: 1988-12-02

Application number

DK605989A

Other languages

English (en)

Other versions

DK174434B1 (da

DK605989D0 (da

Inventor

Christian Congy

Patrick Gueule

Bernard Labeeuw

Murielle Rinaldi

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-12-02

Filing date

1989-11-30

Publication date

1990-06-03

1989-11-30 Application filed by Sanofi Sa filed Critical Sanofi Sa

1989-11-30 Publication of DK605989D0 publication Critical patent/DK605989D0/da

1990-06-03 Publication of DK605989A publication Critical patent/DK605989A/da

2003-03-03 Application granted granted Critical

2003-03-03 Publication of DK174434B1 publication Critical patent/DK174434B1/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
- C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
- C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
- C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
- C07C49/835—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups having unsaturation outside an aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
- C07C2603/24—Anthracenes; Hydrogenated anthracenes

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Furan Compounds (AREA)
Pyridine Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)

DK198906059A 1988-12-02 1989-11-30 Propenonoximethere og fremgangsmåde til fremstilling deraf, farmaceutiske midler indeholdende dem samt mellem produkter til brug ved fremgangsmåden DK174434B1 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR8815860A FR2639942B1 (fr)	1988-12-02	1988-12-02	Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
FR8815860		1988-12-02

Publications (3)

Publication Number	Publication Date
DK605989D0 DK605989D0 (da)	1989-11-30
DK605989A true DK605989A (da)	1990-06-03
DK174434B1 DK174434B1 (da)	2003-03-03

Family

ID=9372544

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK198906059A DK174434B1 (da)	1988-12-02	1989-11-30	Propenonoximethere og fremgangsmåde til fremstilling deraf, farmaceutiske midler indeholdende dem samt mellem produkter til brug ved fremgangsmåden

Country Status (21)

Country	Link
US (2)	US5166416A (da)
EP (1)	EP0373998B1 (da)
JP (1)	JP2562503B2 (da)
KR (1)	KR0156910B1 (da)
AR (1)	AR245704A1 (da)
AU (2)	AU623706B2 (da)
CA (1)	CA2004350C (da)
CZ (1)	CZ419091A3 (da)
DE (1)	DE68908374T2 (da)
DK (1)	DK174434B1 (da)
ES (1)	ES2059804T3 (da)
FI (1)	FI94752C (da)
FR (1)	FR2639942B1 (da)
HK (1)	HK1001557A1 (da)
HU (1)	HU211463A9 (da)
IE (1)	IE63400B1 (da)
IL (1)	IL92519A (da)
NO (1)	NO171269C (da)
NZ (2)	NZ240166A (da)
PT (1)	PT92446B (da)
ZA (1)	ZA899201B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU207988B (en) *	1988-10-20	1993-07-28	Biorex Kutato Fejlesztoe Kft	Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
FR2639942B1 (fr) *	1988-12-02	1991-03-29	Sanofi Sa	Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
IL103106A (en) *	1991-09-25	1998-06-15	Sanofi Elf	Sites of tynocyclopentanone oximes, their preparation and pharmaceutical preparations containing them
HU213421B (en) *	1993-04-09	1997-06-30	Egyt Gyogyszervegyeszeti Gyar	New basic ethers, pharmaceutical compns. containing the said compds. and process for prepg. them
US5844000A (en) *	1997-06-12	1998-12-01	Sanofi	Propenone oxime ethers and pharmaceutical compositions containing them
FR2765107B1 (fr) *	1997-06-26	2000-03-24	Sanofi Sa	Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil
FR2787328A1 (fr) *	1998-12-22	2000-06-23	Sanofi Sa	Utilisation d'un antagoniste des recepteurs 5ht2a pour la preparation de medicaments utiles dans le traitement des ronflements et du syndrome de haute resistance ou de resistance des voies aeriennes superieures
CN1674901A (zh) *	2002-08-05	2005-09-28	桑多斯股份公司	新的地氯雷他定半富马酸盐及其多晶型物
US20050070577A1 (en) *	2003-07-03	2005-03-31	Pfizer Inc.	Compositions containing a serotonin selective reuptake inhibitor and a 5-HT2A receptor antagonist
PT1691811E (pt)	2003-12-11	2014-10-30	Sunovion Pharmaceuticals Inc	Combinação de um sedativo e de um modulador de neurotransmissores e métodos para melhorar a qualidade do sono e tratamento da depressão
ATE423761T1 (de) *	2003-12-26	2009-03-15	Allergan Inc	Disubstituierte chalcogenoxime mit antagonistischer wirkung am rar(gamma)- retinoidrezeptor
EP1799306B1 (en)	2004-09-30	2011-02-23	F. Hoffmann-La Roche AG	Compositions and methods for treating cognitive disorders
US20090076159A1 (en) *	2007-09-19	2009-03-19	Protia, Llc	Deuterium-enriched eplivanserin
EP2236511A4 (en)	2007-12-21	2011-04-13	Alla Chem Llc	LIGANDS OF ALPHA ADRENOCEPTORS AND OF DOPAMINE, HISTAMIN, IMIDAZOLIN AND SEROTONIN RECEPTORS AND THEIR APPLICATION THEREOF
EP2266554A1 (en)	2009-05-26	2010-12-29	Sanofi-Aventis	Method of treating sleep disorders using eplivanserin
EP2186511A1 (en)	2008-11-13	2010-05-19	Sanofi-Aventis	Method of treating sleep disorders using eplivanserin
WO2010055461A1 (en) *	2008-11-13	2010-05-20	Sanofi-Aventis	Method of treating sleep disorders using eplivanserin
FR2938534B1 (fr) *	2008-11-14	2012-10-26	Sanofi Aventis	Procede de preparation de l'hemifumarate d'eplivanserine
EP2397460A4 (en) *	2009-02-10	2012-07-18	Nippon Soda Co	NITROGEN-CONTAINING COMPOUNDS AND AGENTS FOR CONTROLLING HARMFUL ORGANISMS
EP2255726A1 (en)	2009-05-26	2010-12-01	Sanofi-Aventis	Spectral profile of SWS enhancing drugs
EP2255807A1 (en)	2009-05-26	2010-12-01	Sanofi-Aventis	Method of treating sleep disorders using the combination of eplivanserin and zolpidem
EP2269600A1 (en)	2009-07-02	2011-01-05	Sanofi-Aventis	Treatment of sleep disorders using eplivanserin in COPD patients
CN101941919B (zh) *	2009-07-07	2014-07-02	天津药物研究院	一种制备顺式肟及肟醚衍生物的方法
CN106883141B (zh) *	2017-03-15	2018-08-10	何黎琴	一种丹皮酚肟醚类化合物、其制备方法及医药用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1094374A (en) *	1963-11-21	1967-12-13	Gen Aniline & Film Corp	Diazotype materials
NL7503312A (nl) *	1975-03-20	1976-09-22	Philips Nv	Verbindingen met antidepressieve werking.
NL7503310A (nl) *	1975-03-20	1976-09-22	Philips Nv	Verbindingen met antidepressieve werking.
NL7503311A (nl) *	1975-03-20	1976-09-22	Philips Nv	Verbindingen met antidepressieve werking.
US4279930A (en) *	1978-10-10	1981-07-21	The Upjohn Company	Process for treating inflammation
AU532700B2 (en) *	1979-04-02	1983-10-13	Sumitomo Chemical Company, Limited	Diphenylalkanoether
FI92189C (fi) *	1986-03-17	1994-10-10	Eisai Co Ltd	Menetelmä lääkeaineina käyttökelpoisen difenyylimetaanijohdannaisen valmistamiseksi
GB8617648D0 (en) *	1986-07-18	1986-08-28	Ici Plc	Fungicides
KR0139296B1 (ko) *	1988-11-21	1998-05-15	가와무라 시게꾸니	칼콘 유도체 및 그 제조 방법
FR2639942B1 (fr) *	1988-12-02	1991-03-29	Sanofi Sa	Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant

1988
- 1988-12-02 FR FR8815860A patent/FR2639942B1/fr not_active Expired - Fee Related
1989
- 1989-11-29 PT PT92446A patent/PT92446B/pt not_active IP Right Cessation
- 1989-11-29 AU AU45688/89A patent/AU623706B2/en not_active Expired
- 1989-11-30 NO NO894786A patent/NO171269C/no not_active IP Right Cessation
- 1989-11-30 DK DK198906059A patent/DK174434B1/da not_active IP Right Cessation
- 1989-12-01 IE IE384889A patent/IE63400B1/en not_active IP Right Cessation
- 1989-12-01 NZ NZ240166A patent/NZ240166A/en not_active IP Right Cessation
- 1989-12-01 IL IL9251989A patent/IL92519A/en not_active IP Right Cessation
- 1989-12-01 ES ES89403339T patent/ES2059804T3/es not_active Expired - Lifetime
- 1989-12-01 CA CA002004350A patent/CA2004350C/en not_active Expired - Lifetime
- 1989-12-01 ZA ZA899201A patent/ZA899201B/xx unknown
- 1989-12-01 NZ NZ231606A patent/NZ231606A/en unknown
- 1989-12-01 JP JP1313121A patent/JP2562503B2/ja not_active Expired - Lifetime
- 1989-12-01 US US07/444,823 patent/US5166416A/en not_active Expired - Lifetime
- 1989-12-01 FI FI895757A patent/FI94752C/fi active IP Right Grant
- 1989-12-01 DE DE89403339T patent/DE68908374T2/de not_active Expired - Lifetime
- 1989-12-01 AR AR89315585A patent/AR245704A1/es active
- 1989-12-01 EP EP89403339A patent/EP0373998B1/fr not_active Expired - Lifetime
- 1989-12-02 KR KR1019890017809A patent/KR0156910B1/ko not_active IP Right Cessation
1991
- 1991-12-31 CZ CS914190A patent/CZ419091A3/cs unknown
1992
- 1992-03-10 AU AU12183/92A patent/AU640310B2/en not_active Expired
- 1992-07-10 US US07/911,736 patent/US5290951A/en not_active Expired - Lifetime
1995
- 1995-06-28 HU HU95P/P00484P patent/HU211463A9/hu unknown
1997
- 1997-11-26 HK HK97102253A patent/HK1001557A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
AR245704A1 (es)	1994-02-28
PT92446A (pt)	1990-06-29
EP0373998B1 (fr)	1993-08-11
HU211463A9 (en)	1995-11-28
FI94752B (fi)	1995-07-14
PT92446B (pt)	1995-07-18
CA2004350A1 (en)	1990-06-02
NZ231606A (en)	1992-02-25
US5290951A (en)	1994-03-01
FI94752C (fi)	1995-10-25
HK1001557A1 (en)	1998-06-26
JP2562503B2 (ja)	1996-12-11
CZ419091A3 (en)	1993-05-12
NZ240166A (en)	1992-02-25
DE68908374T2 (de)	1994-01-05
IL92519A (en)	1994-05-30
KR900009572A (ko)	1990-07-04
IE63400B1 (en)	1995-04-19
AU623706B2 (en)	1992-05-21
JPH02262552A (ja)	1990-10-25
ZA899201B (en)	1990-09-26
NO171269B (no)	1992-11-09
FI895757A0 (fi)	1989-12-01
EP0373998A1 (fr)	1990-06-20
AU4568889A (en)	1990-06-07
NO894786D0 (no)	1989-11-30
FR2639942A1 (fr)	1990-06-08
DK174434B1 (da)	2003-03-03
KR0156910B1 (ko)	1998-12-01
NO171269C (no)	1993-02-17
DE68908374D1 (de)	1993-09-16
FR2639942B1 (fr)	1991-03-29
AU1218392A (en)	1992-05-28
AU640310B2 (en)	1993-08-19
CA2004350C (en)	1997-06-03
US5166416A (en)	1992-11-24
NO894786L (no)	1990-06-05
DK605989D0 (da)	1989-11-30
IE893848L (en)	1990-06-02
ES2059804T3 (es)	1994-11-16

Publication	Publication Date	Title
DK328586A (da)	1987-01-11	Phenylethanolaminotetraliner og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem
DK605989D0 (da)	1989-11-30	Propenonoximethere og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem
DK61189D0 (da)	1989-02-10	Stabilt, vaeskeformigt vaskemiddel og toejbloedgoeringsmiddel samt fremgangsmaade til fremstilling heraf
DK539789D0 (da)	1989-10-30	Carbostyrilderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant carbostyrilderivat
DK162445C (da)	1992-03-23	Pyranopyridiner, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende pyranopyridinerne
DK128688A (da)	1988-09-13	Thiazolderivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne
DK219387A (da)	1987-10-30	Aminothiazol- og aminooxazolderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK286190D0 (da)	1990-11-30	Glycosaminoglycansalte, fremgangsmaader til fremstilling heraf og farmaceutiske midler indeholdende dem
DK276189A (da)	1989-12-07	Polypeptidforbindelser, fremgangsmaader til fremstilling heraf farmaceutiske midler indeholdende disse
DK560289D0 (da)	1989-11-09	Fluoxetin-analoge, fremgangsmaade til fremstilling heraf og farmaceutiske midler indeholdende saadanne
DK162221C (da)	1992-03-02	Cinnolinforbindelser, fremgangsmaade til fremstilling deraf og farmaceutiske midler indeholdende forbindelserne
DK642588D0 (da)	1988-11-17	Indanderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK592189A (da)	1990-05-26	Nitroimidazoler, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK486789A (da)	1990-04-05	Benzoxazolinonderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK346889A (da)	1990-01-14	Heteropolysaccharid bm07, fremgangsmaade til fremstilling deraf samt anvendelse deraf
DK567188A (da)	1989-04-13	2,2-dimethylchromenderivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne
DK504986A (da)	1987-04-22	7-acylbenzoxazinoner og deres derivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
DK469189D0 (da)	1989-09-22	Substituerede thienopyraner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK674589A (da)	1990-07-01	Benzenderivater og fremgangsmaade til fresmtilling deraf samt farmaceutiske midler indeholdende derivaterne
DK552989A (da)	1990-05-09	Thiazolderivater, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende dem
DK645988D0 (da)	1988-11-18	Biphenylderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeprater indeholdende samme
DK492289A (da)	1990-04-08	3-aryloxymethyl-cephalosporinderivater og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende derivaterne
DK146389A (da)	1989-09-29	(1,3-dioxolan-4-ylmethylthio)phenyl)carbamater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK304789D0 (da)	1989-06-20	Saccharid og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende saccharidet
DK165918C (da)	1993-06-28	4-phenylpiperidinforbindelser, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende forbindelserne

Legal Events

Date	Code	Title	Description
2009-12-21	PUP	Patent expired